Genome editing with sophisticated DNA-cutting enzymes (CRISPR Cas technology) is a hugely important method used in biotechnology. It offers enormous potential for tackling complex challenges, both in the pharmaceutical and diagnostics sector and in the fields of agriculture and industrial biotechnology.

 

By specifically modifying genetic information, we can break new ground. The possibilities are diverse and manifold and we should use them – for the good of humans and nature.